How Pfizer Supports Good Health and Well-Being
Pfizer is proud to support the United Nations Sustainable Development Goals, and specifically Goal 3: Good Health and Well-Being.
Goal 3
Good Health and Well-Being
We promote holistic public health solutions to meet the health needs of the underserved while investing in the well-being of the global community.
We have more than a decade of experience supporting the U.N. Agenda, specifically with respect to health, sustainability, and development.
We support good health every day through the discovery and development of innovative medicines and vaccines, as well as through innovative global health programs and partnerships designed to ensure that underserved individuals around the world are better able to access quality, affordable health care. Our Pfizer Global Health Committee aligns our company-wide resource commitments and focus areas within global public health.
Having established Goal 3 as a critical guide for our company now and into the future, we have taken the next step by incorporating specific SDG targets into our business strategy, designing programs that seek to support progress toward them.
|
Target 3.2 |
By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births. |
|
Progress |
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology | |
|
Target 3.7 |
Ensure universal access to sexual and reproductive healthcare services, including for family planning, information and education. |
|
Progress |
Healthy Families, Healthy Futures: Improving Access to Immunization and Family Planning for Women and Children in Africa | |
|
Target 3.8 |
Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all. |
|
Progress |
Pfizer Partners With Gavi to Supply Our Vaccine to 50 Countries | |
|
Target 3.A |
Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate. |
|
Progress |
Combating the Tobacco Epidemic at a Global Level |
We are also committed to combining our resources with the expertise of our partners to directly support progress of SDGs , , , , and .
Goal 5
Gender Equality
We seek to empower and mobilize women around the world through partnerships aimed at ensuring access to quality healthcare, including newborn immunizations and family planning services.
Goal 6
Clean Water and Sanitation
Through public-private partnerships like the International Trachoma Initiative, as well as efforts to limit our water consumption, we aim to advance public health by improving water supply, sanitation and hygiene.
Goal 9
Industry, Innovation and Infrastructure
We catalyze scientific innovation through cutting-edge research initiatives and unique, results-driven partnerships in order to deliver novel medicines and vaccines to individuals around the world.
Goal 11
Sustainable Cities and Communities
We promote healthy behavior for people of all ages in urban environments through programs to reduce pollution, promote age-friendly policies and improve health services for those most in need.
Goal 12
Responsible Consumption & Production
Throughout the lifecycle of our products, we are working towards reducing our carbon footprint and increasing energy efficiency, decreasing dependence on limited resources and reducing waste.
Goal 17
Partnerships for the Goals
By fueling innovative partnerships to advance public health, including collaborations with NGOs, governments, foundations, social entrepreneurs and colleagues, we are seeking to catalyze creative approaches to accelerate progress and improve care.
You can also download our GRI Reference Table for an expanded view of how Pfizer aligns with the SDGs.
Pfizer GRI Reference Table
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families